Literature DB >> 8688175

Diacylglycerylgalactosides from Arisaema amurense.

J H Jung1, H Lee, S S Kang.   

Abstract

Previously undescribed 1,2-O-diacyl-3-O-beta-D-galactopyranosyl glycerols and 1,2-O-diacyl-3-O-[alpha-D-galactopyranosyl-(1"-->6')-O-beta-D- galactopyranosyl] glycerols were isolated as single components from Arisaema amurense. The cytotoxicities of these compounds against P388 and DLD-1 are described.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8688175     DOI： 10.1016/0031-9422(95)00929-9

Source DB:  PubMed          Journal:  Phytochemistry        ISSN： 0031-9422            Impact factor:   4.072


  6 in total

1.  Two new monogalactosyl diacylglycerols from brown alga Sargassum thunbergii.

Authors:  Young Hwan Kim; Eun-Hee Kim; Chulhyun Lee; Mi-Hee Kim; Jung-Rae Rho
Journal:  Lipids       Date:  2007-03-07       Impact factor: 1.880

2.  New glyceroglycolipid and ceramide from Premna microphylla.

Authors:  Zha-Jun Zhan; Jian-Min Yue
Journal:  Lipids       Date:  2003-12       Impact factor: 1.880

3.  Antineoplastic unsaturated fatty acids from Fijian macroalgae.

Authors:  Ren-Wang Jiang; Mark E Hay; Craig R Fairchild; Jacques Prudhomme; Karine Le Roch; William Aalbersberg; Julia Kubanek
Journal:  Phytochemistry       Date:  2008-08-29       Impact factor: 4.072

4.  Computational Breakthrough of Natural Lead Hits from the Genus of Arisaema against Human Respiratory Syncytial Virus.

Authors:  Kamal Kant; Uma Ranjan Lal; Manik Ghosh
Journal:  Pharmacogn Mag       Date:  2018-01-31       Impact factor: 1.085

5.  De novo sequencing and transcriptome assembly of Arisaema heterophyllum Blume and identification of genes involved in isoflavonoid biosynthesis.

Authors:  Chenkai Wang; Jinhang Zhu; Miaomiao Liu; Qingshan Yang; Jiawen Wu; Zegeng Li
Journal:  Sci Rep       Date:  2018-12-05       Impact factor: 4.379

Review 6.  Botanical, Traditional Use, Phytochemical, and Toxicological of Arisaematis rhizoma.

Authors:  Chun-Yan Qi; Jing Wang; Xu Wu; Su-Rong He; Qiao Zhang; Jian-Hua Wu; Chong-Bo Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-30       Impact factor: 2.629
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.